Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Pharmacogenomics wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Plateau principle wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Drug interaction wikipedia , lookup
Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup
Theralizumab wikipedia , lookup
Evaluation of EDDP (Methadone metabolite) results Cut-off value 100 µg/L Cross-reactivity 100% with EDDP, < 1% with Methadone and EMDP. Metabolism Methadone is rapidly absorbed after oral administration. It undergoes demethylation to up to 8 different metabolites, DDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) and EMDP being the primary metabolites. EDDP will account for 3–25% of the dose in the urinary excretion for the first 24 hours. Urinary excretion of the unchanged drug is dependent on pH, with increased excretion in acid urine. Excretion is relatively slow, and EDDP may be present in urine at levels above the cut off for 2 days after the last dose. Half-life Methadone half-life: •After a single dose •Long-term therapy 10–25 hours 13–55 hours No information is available for the half-life of EDDP. Reasons for the assay Using an assay for EDDP rather than methadone in urine prevents methadone recipients ‘spiking’ their urine with a trace of methadone and passing their methadone to others. Some patients are fast metabolisers of methadone and may give negative results for methadone assays. These patients’ urine will be positive for EDDP. COPYRIGHT © SULLIVAN NICOLAIDES PATHOLOGY 2015 IP250 APRIL 2015